Safe Supply Sells First NIRLAB Drug Analysis Device Under Canadian Distribution Deal

Origin Therapeutics Holdings, Inc. ( (TSE:SPLY) ) has provided an update.

Safe Supply Streaming Co Ltd. has completed its first Canadian sale under its exclusive distribution agreement with NIRLAB SA, providing a NIRLIGHT spectroscopy drug analysis device to Far North Resources Inc. to support Indigenous-led community health and safety initiatives. The deployment places advanced, non-destructive drug identification technology directly in Indigenous communities to enable early risk detection, faster and more informed safety decisions, and real-time data for education and prevention efforts, while also showcasing the device’s broader public-safety and investigative value through near-instant, laboratory-comparable analysis that can materially improve operational effectiveness and reduce uncertainty in time-sensitive environments.

More about Origin Therapeutics Holdings, Inc.

Safe Supply Streaming Co Ltd. is a health and safety technology company focused on rapid-response solutions for drug analysis and public safety. Through an exclusive Canadian distribution agreement with NIRLAB SA, it markets near-infrared spectroscopy devices designed for rapid, non-destructive identification of substances, with a particular emphasis on applications in community health, law enforcement, and broader public-safety environments.

Average Trading Volume: 108,845

Technical Sentiment Signal: Sell

Current Market Cap: C$5.07M

For a thorough assessment of SPLY stock, go to TipRanks’ Stock Analysis page.